BGI Genomics Gets Registration for Expanded Use of Hereditary Deafness Gene Detection Kit
BGI Genomics (SHE:300676) announced a change in the medical device registration of its hereditary deafness gene detection kit.
The changes expanded the use of the kit from auxiliary deafness diagnosis to include serving as a supplement to conventional physical hearing screening, especially to find drug-induced and late-onset deafness gene carriers that are undetectable via conventional physical hearing screening, according to a Thursday filing with the Shenzhen bourse.
Price (RMB): ¥34.68, Change: ¥-0.10, Percent Change: -0.29%